Literature DB >> 23743197

Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer.

Takayuki Nakagawa1, Hiroyuki Endo, Misa Yokoyama, Jiro Abe, Keiichi Tamai, Nobuyuki Tanaka, Ikuro Sato, Satomi Takahashi, Takashi Kondo, Kennichi Satoh.   

Abstract

HOTAIR is one of long non-coding RNAs and its expression correlates with the prognosis and metastasis in various cancers. We showed that HOTAIR expression has an important role in the development of non-small cell lung cancer (NSCLC). In this study, we examined the expression of HOTAIR in 77 NSCLCs, their corresponding normal lung tissues and 6 brain metastases by quantitative real-time RT-PCR. High expression of HOTAIR (tumor/normal ratio ⩾2) was detected in 17 patients (22.1%) and was frequently found in patients with advanced stage, lymph node metastasis or lymph-vascular invasion and short disease free interval. Furthermore, brain metastases show significantly higher HOTAIR expression compared to primary cancer tissues. HOTAIR-expressing A549 cells showed induced cell migration and anchorage-independent cell growth in vitro. These results indicate the expression of HOTAIR enhanced the aggressive behavior of NSCLC cells.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23743197     DOI: 10.1016/j.bbrc.2013.05.101

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  134 in total

1.  A high level of circulating HOTAIR is associated with progression and poor prognosis of cervical cancer.

Authors:  Jing Li; Yuan Wang; Jinjin Yu; Ruofan Dong; Haifeng Qiu
Journal:  Tumour Biol       Date:  2014-10-31

2.  Upregulation of the long noncoding RNA TUG1 promotes proliferation and migration of esophageal squamous cell carcinoma.

Authors:  Youtao Xu; Jie Wang; Mantang Qiu; Lei Xu; Ming Li; Feng Jiang; Rong Yin; Lin Xu
Journal:  Tumour Biol       Date:  2014-10-31

Review 3.  Epigenetics of lung cancer.

Authors:  Scott M Langevin; Robert A Kratzke; Karl T Kelsey
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

4.  lincRNA HOTAIR as a novel promoter of cancer progression.

Authors:  Gregory Loewen; Ying Zhuo; Yan Zhuang; Janarthanan Jayawickramarajah; Bin Shan
Journal:  J Can Res Updates       Date:  2014-07

5.  Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer.

Authors:  Wei-Jing Gong; Jing-Bo Peng; Ji-Ye Yin; Xiang-Ping Li; Wei Zheng; Ling Xiao; Li-Ming Tan; Di Xiao; Yi-Xin Chen; Xi Li; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

Review 6.  Long non-coding RNA HOTAIR in carcinogenesis and metastasis.

Authors:  Jinsong Zhang; Peijing Zhang; Li Wang; Hai-long Piao; Li Ma
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2013-10-27       Impact factor: 3.848

Review 7.  Long non-coding RNA functions in lung cancer.

Authors:  Haiwei Sang; Haihong Liu; Peng Xiong; Min Zhu
Journal:  Tumour Biol       Date:  2015-04-21

8.  lncRNA BANCR promotes EMT in PTC via the Raf/MEK/ERK signaling pathway.

Authors:  Yuanyuan Wang; Jiaojiao Gu; Xiangde Lin; Wei Yan; Wenchao Yang; Guoyang Wu
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

9.  Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in non-functioning pituitary adenomas and their relationship to tumor behavior.

Authors:  Zhenye Li; Chuzhong Li; Chunhui Liu; Shengyuan Yu; Yazhuo Zhang
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

10.  A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.

Authors:  Süleyman Bayram; Ahmet Taner Sümbül; Erdoğan Dadaş
Journal:  Tumour Biol       Date:  2015-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.